
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $2.4B | $2.6B | $3B | $3.7B | $4.3B | |
Revenue Growth (YoY) | 17.98% | 9.36% | 15.15% | 23.27% | 14.24% | |
Cost of Revenues | $2B | $2.2B | $2.5B | $3.1B | $3.6B | |
Gross Profit | $407.5M | $468.2M | $518M | $590.8M | $667.6M | |
Gross Profit Margin | 16.96% | 17.82% | 17.12% | 15.84% | 15.67% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $129.7M | $151.8M | $158.8M | $263M | $225.1M | |
Other Inc / (Exp) | -- | $4.4M | -$3.8M | $6.3M | $7.3M | |
Operating Expenses | $184.3M | $207.7M | $221.2M | $335.4M | $309.3M | |
Operating Income | $223.2M | $260.5M | $296.8M | $255.4M | $358.3M | |
Net Interest Expenses | $5.5M | $6.8M | $3.9M | $8.1M | -- | |
EBT. Incl. Unusual Items | $217.6M | $258M | $289.1M | $272.8M | $386.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $46.2M | $60.3M | $64.4M | $62.9M | $87.6M | |
Net Income to Company | $171.4M | $197.7M | $224.7M | $209.9M | $298.5M | |
Minority Interest in Earnings | -$886K | -$3.1M | $29K | -$451K | -$485K | |
Net Income to Common Excl Extra Items | $170.5M | $194.7M | $224.7M | $209.4M | $298M | |
Basic EPS (Cont. Ops) | $3.19 | $3.57 | $4.09 | $3.76 | $5.26 | |
Diluted EPS (Cont. Ops) | $3.06 | $3.42 | $3.95 | $3.65 | $5.12 | |
Weighted Average Basic Share | $53.4M | $54.5M | $54.9M | $55.7M | $56.7M | |
Weighted Average Diluted Share | $55.8M | $56.9M | $56.9M | $57.3M | $58.2M | |
EBITDA | $281.5M | $320.8M | $360.4M | $353.2M | $478.5M | |
EBIT | $227M | $264.9M | $298M | $280.8M | $394.4M | |
Revenue (Reported) | $2.4B | $2.6B | $3B | $3.7B | $4.3B | |
Operating Income (Reported) | $223.2M | $260.5M | $296.8M | $255.4M | $358.3M | |
Operating Income (Adjusted) | $227M | $264.9M | $298M | $280.8M | $394.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $627.3M | $713.4M | $886.8M | $1B | $1.2B | |
Revenue Growth (YoY) | 6.38% | 13.74% | 24.3% | 13.91% | 16.12% | |
Cost of Revenues | $515.6M | $591.4M | $743M | $851.1M | $984.9M | |
Gross Profit | $111.6M | $122M | $143.9M | $159M | $188.1M | |
Gross Profit Margin | 17.79% | 17.11% | 16.22% | 15.74% | 16.04% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $34.3M | $38.3M | $51.9M | $57.2M | $62.6M | |
Other Inc / (Exp) | $748K | -$816K | $5.5M | $2.9M | $361K | |
Operating Expenses | $47.9M | $52.9M | $69M | $76.8M | $86.7M | |
Operating Income | $63.7M | $69.1M | $74.9M | $82.2M | $101.4M | |
Net Interest Expenses | $1.6M | $2.1M | $2M | $2M | -- | |
EBT. Incl. Unusual Items | $62.8M | $66.2M | $78.4M | $89.6M | $106.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.9M | $16.1M | $18.4M | $20.6M | $26.2M | |
Net Income to Company | $49.8M | $50.1M | $60M | $69M | $80.4M | |
Minority Interest in Earnings | -$631K | $252K | -$117K | -$125K | -$76K | |
Net Income to Common Excl Extra Items | $49.2M | $50.3M | $59.9M | $68.8M | $80.3M | |
Basic EPS (Cont. Ops) | $0.91 | $0.92 | $1.08 | $1.22 | $1.41 | |
Diluted EPS (Cont. Ops) | $0.86 | $0.89 | $1.05 | $1.19 | $1.37 | |
Weighted Average Basic Share | $54.2M | $54.7M | $55.3M | $56.3M | $57.1M | |
Weighted Average Diluted Share | $56.9M | $56.9M | $57.1M | $57.9M | $58.5M | |
EBITDA | $78.1M | $83M | $97.5M | $111.2M | $132.8M | |
EBIT | $64.4M | $68.3M | $80.4M | $91.6M | $108.6M | |
Revenue (Reported) | $627.3M | $713.4M | $886.8M | $1B | $1.2B | |
Operating Income (Reported) | $63.7M | $69.1M | $74.9M | $82.2M | $101.4M | |
Operating Income (Adjusted) | $64.4M | $68.3M | $80.4M | $91.6M | $108.6M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $2.4B | $2.7B | $3.2B | $3.9B | $4.4B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2B | $2.2B | $2.7B | $3.2B | $3.7B | |
Gross Profit | $416.3M | $478.6M | $539.8M | $605.9M | $696.7M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $131.8M | $155.7M | $172.4M | $268.3M | $230.5M | |
Other Inc / (Exp) | $1.6M | $2.8M | $2.5M | $7.6M | $4.8M | |
Operating Expenses | $186.3M | $212.7M | $237.2M | $343.2M | $319.2M | |
Operating Income | $230M | $265.9M | $302.6M | $262.7M | $377.5M | |
Net Interest Expenses | $2.4M | $7.3M | $3.9M | $12M | -- | |
EBT. Incl. Unusual Items | $226.6M | $261.4M | $301.2M | $284M | $403.1M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $46.6M | $63.5M | $66.7M | $65.1M | $93.2M | |
Net Income to Company | $180M | $198M | $234.5M | $218.8M | $309.9M | |
Minority Interest in Earnings | -$1.2M | -$2.2M | -$340K | -$459K | -$436K | |
Net Income to Common Excl Extra Items | $178.8M | $195.8M | $234.2M | $218.4M | $309.4M | |
Basic EPS (Cont. Ops) | $3.34 | $3.59 | $4.25 | $3.89 | $5.45 | |
Diluted EPS (Cont. Ops) | $3.18 | $3.45 | $4.11 | $3.79 | $5.29 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $288.4M | $325.7M | $374.9M | $366.9M | $500.1M | |
EBIT | $233.9M | $268.7M | $310.1M | $292M | $411.4M | |
Revenue (Reported) | $2.4B | $2.7B | $3.2B | $3.9B | $4.4B | |
Operating Income (Reported) | $230M | $265.9M | $302.6M | $262.7M | $377.5M | |
Operating Income (Adjusted) | $233.9M | $268.7M | $310.1M | $292M | $411.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $627.3M | $713.4M | $886.8M | $1B | $1.2B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $515.6M | $591.4M | $743M | $851.1M | $984.9M | |
Gross Profit | $111.6M | $122M | $143.9M | $159M | $188.1M | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $34.3M | $38.3M | $51.9M | $57.2M | $62.6M | |
Other Inc / (Exp) | $748K | -$816K | $5.5M | $2.9M | $361K | |
Operating Expenses | $47.9M | $52.9M | $69M | $76.8M | $86.7M | |
Operating Income | $63.7M | $69.1M | $74.9M | $82.2M | $101.4M | |
Net Interest Expenses | $1.6M | $2.1M | $2M | $2M | -- | |
EBT. Incl. Unusual Items | $62.8M | $66.2M | $78.4M | $89.6M | $106.6M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $12.9M | $16.1M | $18.4M | $20.6M | $26.2M | |
Net Income to Company | $49.8M | $50.1M | $60M | $69M | $80.4M | |
Minority Interest in Earnings | -$631K | $252K | -$117K | -$125K | -$76K | |
Net Income to Common Excl Extra Items | $49.2M | $50.3M | $59.9M | $68.8M | $80.3M | |
Basic EPS (Cont. Ops) | $0.91 | $0.92 | $1.08 | $1.22 | $1.41 | |
Diluted EPS (Cont. Ops) | $0.86 | $0.89 | $1.05 | $1.19 | $1.37 | |
Weighted Average Basic Share | $54.2M | $54.7M | $55.3M | $56.3M | $57.1M | |
Weighted Average Diluted Share | $56.9M | $56.9M | $57.1M | $57.9M | $58.5M | |
EBITDA | $78.1M | $83M | $97.5M | $111.2M | $132.8M | |
EBIT | $64.4M | $68.3M | $80.4M | $91.6M | $108.6M | |
Revenue (Reported) | $627.3M | $713.4M | $886.8M | $1B | $1.2B | |
Operating Income (Reported) | $63.7M | $69.1M | $74.9M | $82.2M | $101.4M | |
Operating Income (Adjusted) | $64.4M | $68.3M | $80.4M | $91.6M | $108.6M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $236.6M | $262.2M | $316.3M | $509.6M | $464.6M | |
Short Term Investments | $13.4M | $13.8M | $15.4M | $17.2M | $62.3M | |
Accounts Receivable, Net | $305.1M | $328.7M | $408.4M | $485M | $569.9M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $27.9M | $5.5M | -- | -- | -- | |
Other Current Assets | -- | $29.6M | $41M | $35M | $60.9M | |
Total Current Assets | $583M | $639.7M | $781.1M | $1B | $1.2B | |
Property Plant And Equipment | $1.8B | $2B | $2.4B | $2.8B | $3.2B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $54.5M | $60.5M | $76.9M | $76.9M | $98M | |
Other Intangibles | $6.6M | $6.4M | $6.4M | $6.5M | $7.3M | |
Other Long-Term Assets | $20.9M | $26.9M | $34.8M | $40.2M | $46.5M | |
Total Assets | $2.5B | $2.9B | $3.5B | $4.2B | $4.7B | |
Accounts Payable | $50.9M | $58.1M | $77.1M | $92.8M | $98.9M | |
Accrued Expenses | $301.4M | $352.7M | $370.7M | $477.1M | $452.4M | |
Current Portion Of Long-Term Debt | $3M | $3.8M | $3.9M | $4M | $4.1M | |
Current Portion Of Capital Lease Obligations | $48.2M | $52.2M | $65.8M | $82.5M | $93.5M | |
Other Current Liabilities | $102M | -- | -- | -- | -- | |
Total Current Liabilities | $562.4M | $523.1M | $582.1M | $734.7M | $743.4M | |
Long-Term Debt | $112.5M | $152.9M | $149.3M | $145.5M | $141.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.7B | $1.8B | $2.2B | $2.7B | $2.8B | |
Common Stock | $58K | $58K | $59K | $60K | $61K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $818.1M | $1B | $1.2B | $1.5B | $1.8B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $150K | $946K | $1.5M | $5.5M | $3.3M | |
Total Equity | $818.2M | $1B | $1.2B | $1.5B | $1.8B | |
Total Liabilities and Equity | $2.5B | $2.9B | $3.5B | $4.2B | $4.7B | |
Cash and Short Terms | $250M | $276M | $331.7M | $526.9M | $526.9M | |
Total Debt | $115.5M | $156.6M | $153.2M | $149.4M | $145.7M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $155.5M | $248.5M | $327M | $511.8M | $282.7M | |
Short Term Investments | $14.6M | $12.1M | $20.1M | $14.5M | $61.8M | |
Accounts Receivable, Net | $312.6M | $339.9M | $444.2M | $519.4M | $584M | |
Inventory | -- | -- | -- | -- | -- | |
Prepaid Expenses | $30.6M | $32.6M | -- | -- | -- | |
Other Current Assets | -- | -- | $39.2M | $42.5M | $57.9M | |
Total Current Assets | $513.3M | $633.1M | $830.5M | $1.1B | $986.4M | |
Property Plant And Equipment | $1.8B | $2.2B | $2.8B | $2.9B | $3.4B | |
Long-Term Investments | -- | $25.4M | -- | -- | -- | |
Goodwill | $54.5M | $76.9M | $76.9M | $77.2M | $106.3M | |
Other Intangibles | $6.4M | $6.4M | $6.3M | $6.6M | $6.9M | |
Other Long-Term Assets | $29.1M | $15.7M | $31.8M | $37M | $80.8M | |
Total Assets | $2.5B | $3B | $3.9B | $4.3B | $4.8B | |
Accounts Payable | $53.9M | $56.9M | $81.5M | $82.6M | $95.3M | |
Accrued Expenses | $268.1M | $330.9M | $347.6M | $446.5M | $394.1M | |
Current Portion Of Long-Term Debt | $2.8M | $3.7M | $3.9M | $4M | $4.1M | |
Current Portion Of Capital Lease Obligations | $50.1M | $57.9M | $77.4M | $85.9M | $97.2M | |
Other Current Liabilities | -- | -- | -- | -- | -- | |
Total Current Liabilities | $443M | $513.6M | $585.3M | $709.7M | $705.2M | |
Long-Term Debt | $111.9M | $152M | $148.3M | $144.5M | $140.6M | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $1.6B | $2B | $2.5B | $2.7B | $2.8B | |
Common Stock | $58K | $58K | $60K | $60K | $61K | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | -$467K | $423K | $1.6M | $5.6M | $3.3M | |
Total Equity | $875.6M | $1.1B | $1.3B | $1.6B | $1.9B | |
Total Liabilities and Equity | $2.5B | $3B | $3.9B | $4.3B | $4.8B | |
Cash and Short Terms | $170.2M | $260.6M | $347.1M | $526.3M | $344.5M | |
Total Debt | $114.7M | $155.7M | $152.2M | $148.5M | $144.7M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $171.4M | $197.7M | $224.7M | $209.9M | $298.5M | |
Depreciation & Amoritzation | $54.6M | $56M | $62.4M | $72.4M | $84.1M | |
Stock-Based Compensation | $14.5M | $18.7M | $22.7M | $30.8M | $36.2M | |
Change in Accounts Receivable | $2.2M | -$30.8M | -$82.4M | -$79.8M | -$84.4M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $373.4M | $275.7M | $272.5M | $376.7M | $347.2M | |
Capital Expenditures | $50.3M | $69.7M | $87.5M | $106.2M | $158.2M | |
Cash Acquisitions | -- | -$8M | -$101.1M | -$69M | -$156.5M | |
Cash From Investing | -$58.7M | -$173.9M | -$186.2M | -$182.7M | -$390.1M | |
Dividends Paid (Ex Special Dividend) | -$10.8M | -$11.5M | -$12.2M | -$12.9M | -$13.7M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $417.2M | $45.2M | $411K | $150K | $400K | |
Long-Term Debt Repaid | -$629.7M | -$3.1M | -$4.1M | -$4M | -$4.4M | |
Repurchase of Common Stock | -$25.9M | -$11.8M | -$31.6M | -$1.9M | -$1.2M | |
Other Financing Activities | $99.3M | -$104.1M | -$4.2M | -$279K | -$5.6M | |
Cash From Financing | -$137.3M | -$76.1M | -$32.3M | -$612K | -$2.2M | |
Beginning Cash (CF) | $59.2M | $236.6M | $262.2M | $316.3M | $509.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $177.4M | $25.6M | $54.1M | $193.4M | -$45M | |
Ending Cash (CF) | $236.6M | $262.2M | $316.3M | $509.6M | $464.6M | |
Levered Free Cash Flow | $323M | $206M | $185M | $270.5M | $188.9M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $49.8M | $50.1M | $60M | $69M | $80.4M | |
Depreciation & Amoritzation | $13.7M | $14.7M | $17.1M | $19.7M | $24.2M | |
Stock-Based Compensation | $4.1M | $5.2M | $6.6M | $8.2M | $10.7M | |
Change in Accounts Receivable | -$15.4M | -$14.1M | -$37.1M | -$35M | -$14.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $34.3M | $45.9M | $48.3M | $35.3M | $72.2M | |
Capital Expenditures | $15.3M | $15.8M | $26.7M | $29.4M | $42.9M | |
Cash Acquisitions | -- | -$16.4M | -- | -$2.4M | -$159.2M | |
Cash From Investing | -$12.2M | -$48.2M | -$36M | -$34.7M | -$243.8M | |
Dividends Paid (Ex Special Dividend) | -$2.9M | -$3M | -$3.2M | -$3.4M | -$3.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$849K | -$979K | -$1M | -$975K | -$1M | |
Repurchase of Common Stock | -$9K | -$9.9M | -$20K | -$14K | -$10.8M | |
Other Financing Activities | -$103.3M | -$146K | -$100K | -$288K | -$11K | |
Cash From Financing | -$103.1M | -$11.3M | -$1.7M | $1.6M | -$10.3M | |
Beginning Cash (CF) | $236.6M | $262.2M | $316.3M | $509.6M | $464.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$81M | -$13.7M | $10.7M | $2.2M | -$181.9M | |
Ending Cash (CF) | $155.5M | $248.5M | $327M | $511.8M | $282.7M | |
Levered Free Cash Flow | $19M | $30M | $21.7M | $5.9M | $29.3M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $180M | $198M | $234.5M | $218.8M | $309.9M | |
Depreciation & Amoritzation | $54.5M | $57M | $64.8M | $74.9M | $88.7M | |
Stock-Based Compensation | $15.3M | $19.8M | $24.1M | $32.4M | $38.7M | |
Change in Accounts Receivable | $8.6M | -$29.4M | -$105.4M | -$77.6M | -$64M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $380.5M | $287.3M | $275M | $363.6M | $384.1M | |
Capital Expenditures | $49.9M | $70.2M | $98.4M | $109M | $171.7M | |
Cash Acquisitions | -- | -$24.4M | -$84.7M | -$71.5M | -$313.3M | |
Cash From Investing | -$55.3M | -$209.9M | -$173.9M | -$181.4M | -$599.2M | |
Dividends Paid (Ex Special Dividend) | -$11M | -$11.7M | -$12.3M | -$13.1M | -$13.9M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$389.9M | -$3.2M | -$4.1M | -$4M | -$4.4M | |
Repurchase of Common Stock | -$926K | -$21.7M | -$21.7M | -$1.9M | -$12M | |
Other Financing Activities | -$3.2M | -$978K | -$4.1M | -$467K | -$5.3M | |
Cash From Financing | -$232.9M | $15.7M | -$22.6M | $2.6M | -$14.1M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $92.3M | $93M | $78.4M | $184.9M | -$229.2M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $330.7M | $217.1M | $176.6M | $254.7M | $212.4M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $49.8M | $50.1M | $60M | $69M | $80.4M | |
Depreciation & Amoritzation | $13.7M | $14.7M | $17.1M | $19.7M | $24.2M | |
Stock-Based Compensation | $4.1M | $5.2M | $6.6M | $8.2M | $10.7M | |
Change in Accounts Receivable | -$15.4M | -$14.1M | -$37.1M | -$35M | -$14.6M | |
Change in Inventories | -- | -- | -- | -- | -- | |
Cash From Operations | $34.3M | $45.9M | $48.3M | $35.3M | $72.2M | |
Capital Expenditures | $15.3M | $15.8M | $26.7M | $29.4M | $42.9M | |
Cash Acquisitions | -- | -$16.4M | -- | -$2.4M | -$159.2M | |
Cash From Investing | -$12.2M | -$48.2M | -$36M | -$34.7M | -$243.8M | |
Dividends Paid (Ex Special Dividend) | -$2.9M | -$3M | -$3.2M | -$3.4M | -$3.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | -- | -- | -- | -- | |
Long-Term Debt Repaid | -$849K | -$979K | -$1M | -$975K | -$1M | |
Repurchase of Common Stock | -$9K | -$9.9M | -$20K | -$14K | -$10.8M | |
Other Financing Activities | -$103.3M | -$146K | -$100K | -$288K | -$11K | |
Cash From Financing | -$103.1M | -$11.3M | -$1.7M | $1.6M | -$10.3M | |
Beginning Cash (CF) | $236.6M | $262.2M | $316.3M | $509.6M | $464.6M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$81M | -$13.7M | $10.7M | $2.2M | -$181.9M | |
Ending Cash (CF) | $155.5M | $248.5M | $327M | $511.8M | $282.7M | |
Levered Free Cash Flow | $19M | $30M | $21.7M | $5.9M | $29.3M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.